Zobrazeno 1 - 10 of 24 pro vyhledávání: '"H. J. van Beekhuizen"'
1
Akademický článek
Acute and long-term toxicity in patients undergoing induction chemotherapy followed by thermoradiotherapy for advanced cervical cancer
Autor: X. S. Gao, I. A. Boere, H. J. van Beekhuizen, M. Franckena, R. Nout, M. J. H. A. Kruip, M. D. Kulawska, H. C. van Doorn
Publikováno v: International Journal of Hyperthermia, Vol 39, Iss 1, Pp 1440-1448 (2022)
Objectives To determine rates of vascular toxicity, acute kidney injury (AKI), chronic kidney disease (CKD) and survival in high-risk cervical cancer patients treated with platinum-based induction chemotherapy followed by thermoradiotherapy.Methods B
Externí odkaz: https://doaj.org/article/ea259be1138d4381b4fc460ea3662354
Zobrazit plný text záznamu
2
Akademický článek
Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial
Autor: R. L. O. van de Laar, W. Hofhuis, R. G. Duijnhoven, S. Polinder, W. J. G. Melchers, F. J. van Kemenade, R. L. M. Bekkers, H. J. Van Beekhuizen
Publikováno v: BMC Cancer, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Cervical cancer is caused by Human Papilloma viruses (HPV) and is preceded by precursor stages: Cervical Intraepithelial Neoplasia (CIN). CIN is mostly found in women in their reproductive age and treated with a Loop Electrosurgic
Externí odkaz: https://doaj.org/article/7056e259a6b34b9ba202fbd2bc1cb2e0
Zobrazit plný text záznamu
3
Akademický článek
Evaluation of effectiveness of the PlasmaJet surgical device in the treatment of advanced stage ovarian cancer (PlaComOv-study): study protocol of a randomized controlled trial in the Netherlands
Autor: G. M. Nieuwenhuyzen-de Boer, W. Hofhuis, N. Reesink-Peters, P. C. Ewing-Graham, I. G. Schoots, J. J. Beltman, J. M. J. Piek, A. Baalbergen, G. S. Kooi, A. van Haaften, H. van Huisseling, L. Haans, M. Dorman, H. J. van Beekhuizen
Publikováno v: BMC Cancer, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background The most important goal for survival benefit of advanced stage ovarian cancer is to surgically remove all visible tumour, because complete cytoreductive surgery (CCS) has been shown to be associated with prolonged survival. In a r
Externí odkaz: https://doaj.org/article/22bb437acc844c01ad210ce91aa2bf53
Zobrazit plný text záznamu
4
Akademický článek
TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial
Autor: A. J. M. van de Sande, M. M. Koeneman, C. G. Gerestein, A. J. Kruse, F. J. van Kemenade, H. J. van Beekhuizen
Publikováno v: BMC Cancer, Vol 18, Iss 1, Pp 1-6 (2018)
Abstract Background Cervical dysplasia (cervical intraepithelial neoplasia (CIN)) is caused by Human Papillomavirus (HPV) and is most common in women of reproductive age. Current treatment of moderate to severe CIN is surgical. This procedure has pot
Externí odkaz: https://doaj.org/article/e64fd0651df9469cadf1b218e72121cf
Zobrazit plný text záznamu
6
Treatment of Residual or Recurrent CIN with Topical Imiquimod: a Retrospective Study
Autor: Arnold-Jan Kruse, R. van Baars, F. J. van Kemenade, A. J. M. van de Sande, C. G. Gerestein, H. J. van Beekhuizen, M. M. Koeneman
Publikováno v: Roumanian Archives of Microbiology and Immunology, 4(3), 95-109. Institutul Cantacuzino
Objective In this retrospective case study, we determine the results, side effects and long-term outcome features of treatment with imiquimod 5% in women with recurrent or residual cervical intraepithelial neoplasia (rrCIN). Methods The study was set
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d76ea34d2071a12659103feac1ad84dd
https://doi.org/10.26502/ami.93650049
Zobrazit plný text záznamu
9
Retrospective study of a 16 year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: Prevalence of invasive and in-situ carcinoma, with follow-up
Autor: Winand N.M. Dinjens, E.M. Roes, Patricia C. Ewing-Graham, Shatavisha Dasgupta, H. J. van Beekhuizen, F. Blok
Publikováno v: Gynecologic Oncology, 153(2), 326-334. Academic Press
Objectives Carriers of BRCA1 and BRCA2 mutations are at increased risk of high grade serous carcinoma and are therefore offered risk-reducing salpingo-oophorectomy (RRSO) by 40–45 years. Most of these carcinomas are believed to arise in the fallopi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5569f81bcdc86fe95701b7200af892ad
https://doi.org/10.1016/j.ygyno.2019.03.003
Zobrazit plný text záznamu
10
Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial
Autor: Ruud L.M. Bekkers, Willem J. G. Melchers, H. J. van Beekhuizen, W. Hofhuis, Ruben G. Duijnhoven, Suzanne Polinder, R. L. O. van de Laar, F. J. van Kemenade
Publikováno v: BMC Cancer, 20
BMC cancer, 20(1):539. BioMed Central
BMC Cancer, 20, 1
BMC Cancer, 20(1):539. BioMed Central Ltd
BMC Cancer, Vol 20, Iss 1, Pp 1-7 (2020)
BMC Cancer, 20(1):539. BioMed Central Ltd.
BMC Cancer
Background Cervical cancer is caused by Human Papilloma viruses (HPV) and is preceded by precursor stages: Cervical Intraepithelial Neoplasia (CIN). CIN is mostly found in women in their reproductive age and treated with a Loop Electrosurgical Excisi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39b1d479dc428400bc4d3e45cf63e066
https://hdl.handle.net/1765/127869
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje